Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
The biopharmaceutical industry is approaching a defining moment. Scientific breakthroughs across cell and gene therapies, precision oncology and novel biologics are accelerating faster than the systems designed to test them. This perspective is informed by recent industry thought leadership, including insights published by McKinsey & Company on...
In an industry defined by scientific complexity, global regulatory shifts and rising expectations for speed and quality, pharma and biotech organizations increasingly rely on life sciences consulting services that offer both strategic foresight and operational depth. Navitas Life Sciences stands apart as a pharma and biotech advisory partner with t...
Patient registries have become one of the most powerful tools Foundations can use to advance research, improve care and amplify the patient voice. They inform real-world evidence generation. They guide standards of care. They influence policy, funding and therapeutic development. And yet, many registries fail quietly. Not because of poor intent or ...
From Regulatory Necessity to Strategic Advantage AI in Labeling is emerging as an important milestone. After all, labeling has long been one of the most critical yet understated functions in life sciences. For years, its primary mandate was to ensure compliance, reflect approved data accurately and meet regulatory expectations across markets. The w...
In life sciences outsourcing, few terms are used as interchangeably, and as confusingly, as Contract Research Organisation and Clinical Research Organisation. Both are commonly shortened to CRO, both support sponsors across drug development, and both play a critical role in bringing therapies to patients faster. So what actually differentiates a Co...
How AI in Clinical Trials, Decentralized Clinical Trials and Real-World Evidence (RWE) Are Redefining Research Clinical research is entering 2026 with rising complexity and rising expectations. Sponsors are under pressure to accelerate development timelines, manage global operations, meet evolving regulatory requirements and deliver patient-centric...
A Year of Impact 2025 was a year of progress and partnership, where sponsors looked for the best CRO partner for global clinical trials, demanded inspection-ready clinical trial support for EMA inspections and needed teams that could deliver under pressure without compromising quality. Navitas Life Sciences worked alongside partners across clinical...
The Navitas Advantage: Powering the Future of Pharma & Biotech In today’s fast-moving world of pharma and biotech, innovation isn’t just an advantage—it’s a necessity. Scientific breakthroughs, evolving global regulations, and the relentless demand for speed and quality are rewriting the rules of drug development. To...
In a world where scientific innovation is accelerating fast, regulatory strategy is a competitive advantage. Pharma & biotech companies need clarity and deep multidisciplinary insight into the regulatory environment and the paths that competitors are taking to bring safe, effective products to market quickly. Whether developing a first-in-class...
Are you ready to lead the next wave of transformation in life sciences? Across Navitas’ industry-leading networks, pvnet®, pvconnect®, labelnet™, and more, over 100+ member companies are rewriting the playbook for 2026. Here’s what’s setting the pace for the industry’s boldest innovators: 1. Technology &...